IP Library › Granted Patent US 10,501,731
Granted Patent B2
US 10,501,731 · App. 15/845,572 · Granted Dec 10, 2019

Degradable clostridial toxins

Inventors: Lance E. Steward (Irvine, CA); Sanjiv Ghanshani (Irvine, CA); Ester Fernandez-Salas (Ann Arbor, MI); Marcella A. Gilmore (Santa Ana, CA); Joseph Francis (Aliso Viejo, CA); Kei Roger Aoki (Coto de Caza, CA)
Assignee: Allergan, Inc.
C12N9/52A61K38/4893C07K14/33C12Y304/24069
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,501,731
App. No.
15/845,572
Granted
Dec 10, 2019
Kind
B2
Abstract

The specification discloses Clostridial toxins or Clostridial toxin chimeras comprising an inactivation cleavage site, polynucleotide molecules encoding such toxins or chimeras, compositions comprising such toxins or chimeras, and method of producing such toxins or chimeras.

Claims (5)

1. A non-naturally occurring Clostridial toxin comprising at least one exogenous protease cleavage site located within an inactivation cleavage site region, wherein the inactivation cleavage site region is located

in the translocation domain and/or the N-terminal subdomain of the binding domain (H CN ), wherein the at least one exogenous protease cleavage site comprises a dual Thrombin-Thrombin cleavage site, a Factor Xa cleavage site, a dual Factor Xa-Thrombin cleavage site, and/or a Matrix Metalloproteinase-9 (MMP-9) cleavage site, and

wherein the inactivation cleavage site region comprises a variant of SEQ ID NO:1 comprising the at least one exogenous protease site in amino acids 871-895 of SEQ ID NO: 1.

2. The Clostridial toxin of claim 1 , further comprising a botulinum toxin type A (BoNT/A) enzymatic domain.

3. The non-naturally occurring Clostridial toxin of claim 1 , comprising at least an amino acid sequence selected from the group consisting of the amino acid sequence of SEQ ID: 531, SEQ ID NO: 533, SEQ ID NO: 535 and SEQ ID NO: 537.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 18, 2017
From: STEWARD, LANCE E.; GHANSHANI, SANJIV; FERNANDEZ-SALAS, ESTER; GILMORE, MARCELLA A.; FRANCIS, JOSEPH; AOKI, KEI ROGER
To: ALLERGAN, INC.
Reel/Frame 044424/0419 →
Continuity (6)
Continuation 15082635 · Mar 28, 2016
Continuation 14088022 · Nov 22, 2013
Division 13846364 · Mar 18, 2013
Division 13112844 · May 20, 2011
Provisional Application 61346578 · May 20, 2010
Related Publication 20180119126A1 · May 3, 2018
Cited By (1)
US 12,421,284